Indicators of systemic inflammation in critically ill patients with COVID-19. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021
SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae Source: ERJ Open Res, 8 (1) 00706-2021; 10.1183/23120541.00706-2021 Year: 2022
How can I prevent infectious complications in critically ill patients? Source: Annual Congress 2008 - PG13 - Respiratory failure: skills needed to treat an episode of acute respiratory failure Year: 2008
Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury Source: Eur Respir J 2009; 33: 1403-1414 Year: 2009
Resistin may predict severity and mortality in critically ill septic patients Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers Year: 2018
A haplotype of the endothelial protein C receptor gene is associated with reduced risk of acute lung injury in critically ill patients Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment Year: 2011
Altered phenotype of blood dendritic cells in patients with acute pneumonia Source: Annual Congress 2011 - Phagocytes and dendritic cells Year: 2011
Risk factors and outcomes of severe influenza pneumonia with bacterial co-infection in critically ill patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017
Treating acute complications and the severely ill patient with tuberculosis Source: International Congress 2018 – PG13 Challenges in the treatment of tuberculosis Year: 2018
Th1\Th2 lymphocyte response during the course of lung infection in CF children Source: Eur Respir J 2006; 28: Suppl. 50, 484s Year: 2006
Diagnostic and prognostic value of CD4, CD8, CD4/CD8 definition in blood at pneumonia of various etiology Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013
Serum miR-122 levels correlated to the coagulation disorders of severe sepsis patients Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013
Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19. Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020 Year: 2021
Increased circulating levels of angiotensin-(1–7) in severely ill COVID-19 patients Source: ERJ Open Res, 7 (3) 00114-2021; 10.1183/23120541.00114-2021 Year: 2021
²Many-armed" CD4: Why it is necessary to count blood CD4 at patient with severe community-acquired pneumonia (CAP)? Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
The profile of dendritic cell and T cell response is related to the viral trigger in children with severe asthma exacerbation Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012
LATE-BREAKING ABSTRACT: Plasma level of TRAIL is associated with severity of sepsis and predicts survival after critical illness Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016
T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients Source: Eur Respir J 2006; 28: Suppl. 50, 344s Year: 2006
Adrenocortical state in critically ill infants and children with pnuemonia complicated by sepsis and septic shock Source: International Congress 2019 – Neonatal and paediatric intensive care Year: 2019